Imagine you, you in a nice comfy seat, with your hands behind your head, taking in the views,

instead of taking on the road, maybe even taking a nap. That's the bliss of getting where you need to go

without worrying about driving. Book your train journey via avantiwestcoast.coast.com.

And we'll take you there.

Avanti West Coast.

Feel good travel.

Hello and welcome to Backchat.

If the Nature podcast is an assignment smugly turned in two weeks ahead of the

deadline, then Backchat is doing your homework on the bus on the way to school. Yes, Backchats back.

And listeners, if you're new to the show, it's a bit different to the regular Nature podcast

and is more of a personal take on the latest stories from our team of reporters and editors.

In today's roundtable discussion, we'll be crunching

the numbers and looking at data journalism, finding out the best way to squeeze a science story

into a single sentence, and learning how CRISPR gene editing is editing stock market prices.

I'm Benjamin Thompson, and joining me on today's show are Heidi Ledford. Hi, I'm Heidi

Ledford. I'm a reporter with nature.

Richard Van Norton. Hello, I'm Richard Norton and I edit nature's features. And making her back chat

debut, it's Flora Graham. Hi, I'm Flora Graham and I'm editor of Nature Briefing. Coming up in the show,

we'll be talking about the results of a nature survey on lab health? What did it reveal about research groups around the world? And when we're deluge with data, how do we pick out what's important for a story?

We'll also be looking at email briefings. Are they having a golden age? What makes a good one?

And how much can you compress a story before it loses all meaning?

Finally, seemingly rather technical research findings are having sizable waves in the stock market.

...